News

Thank you for standing by, and welcome to the Krystal Biotech First Quarter 2025 Earnings Call. At this time, all participants are on a listen-only mode. After the speakers' presentations, there will ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...
A recovery from this prolonged and painful market downturn will require a major attitude adjustment from biotech management ...
The annual event, which is on pace toward a goal of 8,000 attendees, will be a whirlwind of sessions, keynotes, fireside chats, posters ... to talk about these topics with our president over ...
UnitedHealth Group (UNH) stock drops as its CEO steps down, and the company suspends its 2025 outlook amid rising medical ...
The SPDR S&P Biotech ETF and big pharma giants like Merck were lower in early trading Monday. Chat-GPT-parent OpenAI made plans over the weekend to renegotiate its partnership with Microsoft to ...
“As the title suggests, it feels like in this day and age weekends should have no bearing on fluid movement of funds,” wrote the original poster. Mode Mobile developed a smartphone called ...
A Redditor knew this detail when asking for advice in the Dividends subreddit. The original poster has $100,000 invested in the Vanguard S&P 500 ETF VOO and stated that you're "basically a ...
A Philadelphia entrepreneur developing eye repair tech stood out among international contenders as it gears up to raise a ...
The SPDR S&P Biotech ETF and big pharma giants like Merck were lower in early trading Monday. The geopolitical backdrop also provided welcome news for Wall Street. Over the weekend, news broke ...
Agendia®, Inc., announced today that new data on its comprehensive genomic tests will be presented at the American Society of ...